Drug Discovery Informatics Market Size, Share, Growth, Trends
According to IMARC Group’s latest report, titled “Drug Discovery Informatics Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2027”, the global informatics market size in drug discovery reached US$2.7 billion in 2021. IMARC Group expects the market to reach US$5.1 billion by 2027, growing at a CAGR of 11.62% during of the period 2022-2027.
COVID-19 impact analysis:
We regularly monitor the direct effect of COVID-19 on the market, as well as the indirect influence of associated industries. These observations will be incorporated into the report.
Download the free sample report brochure: https://www.imarcgroup.com/drug-discovery-informatics-market/requestsample
Industry overview and application:
Drug Discovery Informatics (DDI) is a technical solution used to discover new treatments and develop effective drugs through extensive research and screening. It uses sophisticated bioinformatics algorithms to process biomechanical data related to drugs, proteins, diseases, pathways, gene expression and sequence data. It also encompasses various hardware and software solutions to protect databases and cost-effectively search, anchor, interpret, visualize and prepare drug formulations. In addition, DDI analyzes new drug entities, manages biological information from multiple sources, and performs several pharmacovigilance tasks and post-trial clinical decisions.
Market Trends and Drivers:
The rising prevalence of various chronic disorders, especially among the geriatric population, and the growing need for effective drugs at affordable prices are driving the growth of the drug discovery informatics market. Moreover, the outbreak of the coronavirus disease (COVID-19) pandemic has prompted governments to invest in the pharmaceutical industry to formulate vaccines, which, in turn, increases the demand for products. Apart from this, substantial improvements in healthcare infrastructure, the advent of in silico tools and a physiologically based pharmacokinetic (PBK) simulator to select pediatric doses, and research and development activities (R&D) ongoing to improve the computational efficiency of drug discovery is supporting the growth of the market.
Competitive Analysis and Segmentation of the Drug Discovery Informatics Market 2022-2027:
Competitive landscape with key players:
The competitive landscape of the Drug Discovery Informatics market has been studied in the report along with the detailed profiles of key players operating in the market.
Some of these key players include:
• Charles River Laboratories Inc.
• Collaborative Drug Discovery Inc.
• Eurofins DiscoverX products
• Infosys Ltd.
• International Commercial Machinery Society
• Jubilant Biosys Limited
• Oracle Corporation
• Perkin Elmer Inc.
• Thermo Fisher Scientific Inc.
Key Market Segmentation:
The report has segmented the global drug discovery informatics market on the basis of workflow, function, mode, end-user, and region.
Breakdown by Workflow:
• Drug discovery
• Drug development
Breakdown by function:
• Sequence analysis platforms
• Molecular modeling
• Molecular docking
• Management of clinical trial data
Breakdown by mode:
Breakdown by end user:
• Pharmaceutical companies
• Biotechnology companies
• Contract Research Organization (CRO)
Breakdown by region:
• North America
• Asia Pacific
• Latin America
• Middle East and Africa
Ask the analyst for a customization and explore the full report with table of contents and list of figures: https://www.imarcgroup.com/request?type=report&id=3515&flag=C
Main highlights of the report:
• Market performance (2016-2021)
• Market Outlook (2022-2027)
• Market trends
• Market drivers and success factors
• Impact of COVID-19
• Value chain analysis
• Complete mapping of the competitive landscape
If you need specific information that is not currently covered in the report, we will provide it to you as part of the customization.
The IMARC Group is a leading market research firm providing management strategies and market research worldwide. We partner with clients across all industries and geographies to identify their most important opportunities, address their most critical challenges and transform their businesses.
IMARC’s information products include major business, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high-tech organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverages, travel and tourism, nanotechnology and new processing methods are at the top of the list. company expertise.
Our offerings include comprehensive market information in the form of research reports, production cost reports, feasibility studies and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium-sized businesses to Fortune 1000 companies.
30 N Gould St, Ste R
Sheridan, WY 82801, United States
Email: [email protected]
Americas: +1-631-791-1145 | Europe and Africa: +44-753-713-2163 | Asia: +91-120-433-0800
This press release was published on openPR.